Gellerman G - Search Results

1

Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery.

Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G. Gilad Y, et al. Among authors: gellerman g. Bioorg Med Chem. 2016 Jan 15;24(2):294-303. doi: 10.1016/j.bmc.2015.12.020. Epub 2015 Dec 12. Bioorg Med Chem. 2016. PMID: 26719208

2

A backbone-cyclic, receptor 5-selective somatostatin analogue: synthesis, bioactivity, and nuclear magnetic resonance conformational analysis.

Gilon C, Huenges M, Mathä B, Gellerman G, Hornik V, Afargan M, Amitay O, Ziv O, Feller E, Gamliel A, Shohat D, Wanger M, Arad O, Kessler H. Gilon C, et al. Among authors: gellerman g. J Med Chem. 1998 Mar 12;41(6):919-29. doi: 10.1021/jm970633x. J Med Chem. 1998. PMID: 9526566

3

Targeted drug delivery for cancer therapy: the other side of antibodies.

Firer MA, Gellerman G. Firer MA, et al. Among authors: gellerman g. J Hematol Oncol. 2012 Nov 9;5:70. doi: 10.1186/1756-8722-5-70. J Hematol Oncol. 2012. PMID: 23140144 Free PMC article. Review.

4

Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide.

Gellerman G, Baskin S, Galia L, Gilad Y, Firer MA. Gellerman G, et al. Anticancer Drugs. 2013 Feb;24(2):112-9. doi: 10.1097/CAD.0b013e32835bb17a. Anticancer Drugs. 2013. PMID: 23187462

5

"Switch off/switch on" regulation of drug cytotoxicity by conjugation to a cell targeting peptide.

Gilad Y, Firer MA, Rozovsky A, Ragozin E, Redko B, Albeck A, Gellerman G. Gilad Y, et al. Among authors: gellerman g. Eur J Med Chem. 2014 Oct 6;85:139-46. doi: 10.1016/j.ejmech.2014.07.073. Epub 2014 Jul 22. Eur J Med Chem. 2014. PMID: 25084142

6

Antiproliferative Effect of Novel Aminoacridine-based Compounds.

Munder A, Moskovitz Y, Redko B, Levy AR, Ruthstein S, Gellerman G, Gruzman A. Munder A, et al. Among authors: gellerman g. Med Chem. 2015;11(4):373-82. doi: 10.2174/1573406411666141217110946. Med Chem. 2015. PMID: 25524547

7

α-Aminoisobutyric Acid Leads a Fluorescent syn-bimane LASER Probe Across the Blood-brain Barrier.

Lapidot I, Baranes D, Pinhasov A, Gellerman G, Albeck A, Grynszpan F, Shatzmiller SE. Lapidot I, et al. Among authors: gellerman g. Med Chem. 2016;12(1):48-53. doi: 10.2174/1573406411666150518105010. Med Chem. 2016. PMID: 25981518

8

Biolabile peptidyl delivery systems toward sequential drug release.

Ragozin E, Redko B, Tuchinsky E, Rozovsky A, Albeck A, Grynszpan F, Gellerman G. Ragozin E, et al. Among authors: gellerman g. Biopolymers. 2016 Jan;106(1):119-32. doi: 10.1002/bip.22794. Biopolymers. 2016. PMID: 26662352

9

Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells.

Gilad Y, Noy E, Senderowitz H, Albeck A, Firer MA, Gellerman G. Gilad Y, et al. Among authors: gellerman g. Biopolymers. 2016 Mar;106(2):160-171. doi: 10.1002/bip.22800. Biopolymers. 2016. PMID: 26715008

10

Toward the development of a novel non-RGD cyclic peptide drug conjugate for treatment of human metastatic melanoma.

Redko B, Tuchinsky H, Segal T, Tobi D, Luboshits G, Ashur-Fabian O, Pinhasov A, Gerlitz G, Gellerman G. Redko B, et al. Among authors: gellerman g. Oncotarget. 2017 Jan 3;8(1):757-768. doi: 10.18632/oncotarget.12748. Oncotarget. 2017. PMID: 27768593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

51 results

Search Page

Filters